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Abstract
Background: Particulate air pollution is reported to cause adverse health effects in susceptible
individuals. Since most of these particles are derived form combustion processes, the primary
composition product is carbon with a very small diameter (ultrafine, less than 100 nm in diameter).
Besides the induction of reactive oxygen species and inflammation, ultrafine particles (UFP) can
cause intracellular calcium transients and suppression of defense mechanisms of alveolar
macrophages, such as impaired migration or phagocytosis.
Methods: In this study the role of intracellular calcium transients caused by UFP was studied on
cytoskeleton related functions in J774A.1 macrophages. Different types of fine and ultrafine carbon
black particles (CB and ufCB, respectively), such as elemental carbon (EC90), commercial carbon
(Printex 90), diesel particulate matter (DEP) and urban dust (UD), were investigated. Phagosome
transport mechanisms and mechanical cytoskeletal integrity were studied by cytomagnetometry
and cell viability was studied by fluorescence microscopy. Macrophages were exposed in vitro with
100 and 320 µg UFP/ml/million cells for 4 hours in serum free medium. Calcium antagonists
Verapamil, BAPTA-AM and W-7 were used to block calcium channels in the membrane, to chelate
intracellular calcium or to inhibit the calmodulin signaling pathways, respectively.
Results: Impaired phagosome transport and increased cytoskeletal stiffness occurred at EC90 and
P90 concentrations of 100 µg/ml/million cells and above, but not with DEP or UD. Verapamil and
W-7, but not BAPTA-AM inhibited the cytoskeletal dysfunctions caused by EC90 or P90.
Additionally the presence of 5% serum or 1% bovine serum albumin (BSA) suppressed the
cytoskeletal dysfunctions. Cell viability showed similar results, where co-culture of ufCB together
with Verapamil, W-7, FCS or BSA produced less cell dead compared to the particles only.
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Background
Epidemiological studies suggest increased health risks
(decreased lung function, increased morbidity and mor-
tality) after exposure to environmental particles [1,2].
Recent epidemiological studies show, that not only the
mass of inhaled urban particles (i.e. PM10 or PM2.5 ≡
mass of all particles being smaller than 10 µm or 2.5 µm,
respectively) is associated with increased morbidity and
mortality, but also the number of particles with even
higher significance [3,4]. Because of the smaller mass of
ultrafine (diameter < 100 nm) compared to fine particles,
they contribute little to the total mass, but are important
in the overall number of particles. Most urban particles
result from combustion processes; therefore the dominant
fraction contains ultrafine carbonaceous particles. These
particles are less soluble and therefore can reside in the
lung for longer times. Larger particles and bacteria are
phagocytized by alveolar and airway macrophages and
dendritic cells within hours and further digested, keeping
the lung surface in a sterile condition (under physiologi-
cal conditions). UFP are not only phagocytosed by alveo-
lar macrophages, but can enter epithelial cells, can
penetrate into the circulation, being further redistributed
to other organs of the body [5]. Therefore, UFP can reach
sites in the body far away from the site of entrance, where
they can cause inflammatory reactions, in contrast to
larger particles [6,7]. With decreasing particle size the par-
ticle surface increases in relation to the particle volume or
particle mass. Particles forming aggregates being com-
posed of subunits of much smaller size can further
enhance their surface area in relation to the mass (specific
surface area). Because of their high specific surface area,
UFP can catalyze chemical reactions, which may induce
chronic inflammation. Animal studies and in vitro cell
studies have shown that high concentrations of ultrafine
particles can induce inflammatory processes and
increased calcium transients [8-13], can induce the pro-
duction of reactive oxygen species (ROS, like H2O2, O2
-)
[14-16], can induce oxidation of cytoskeletal proteins
[17,18] and cytoskeletal dysfunctions [19,20], or can act
as vehicles to transport toxic gasses and substances to the
lung periphery [21].
Phagocytic cells in the lung, such as macrophages, poly-
morphonuclear leukocytes and dendritic cells play a key-
role in the defense-reaction. They ingest foreign materials,
digest bacteria and viruses, and present antigens in order
to trigger specific (immunological) defense mechanisms
[22-24]. Macrophages reside in the alveoli and chemotac-
tic gradients direct the macrophages within minutes to the
site of particle deposition. During phagocytosis the parti-
cles are incorporated into a membranous vesicle and
ingested into intracellular phagosomes, which fuse with
lysosomes [25]. Phagolysosomes are acidic (pH ≈ 5) and
contain reactive oxygen species (H2O2) [26,27]. They are
the site where most bacteria and fungi are digested. Non-
digestible particles are retained in the lung for longer peri-
ods of time, for example iron oxide tracer particles have a
clearance half-time of 120 days in healthy non-smoking
subjects [28]. UFP are not only engulfed by phagocytosis
and therefore must not necessarily reside in phagolyso-
somes, which may imply much longer residence times in
the lung. The cytoskeleton of the AM is crucially involved
in the phagocytic defense reactions, including locomotion
and cell migration, phagocytosis, intracellular transport,
phagosome-lysosome fusion and signal transduction [29-
31]. The cytoskeleton consists of three different filamen-
tous structures. Microfilaments (actin) are involved in
dynamic processes of the cell, like crawling and phagocy-
tosis. Microtubuli are involved in cell shape and intracel-
lular vesicle transport. Intermediate filaments contribute
to the static part of the cytoskeleton. Every filamentous
structure has its own family of motor proteins being
responsible for the transport of molecules and vesicles
[32]. Those transport processes require energy in the form
of ATP [33,34]. The cytoskeleton is sensitive to ROS and
oxidative stress, due to the presence of thiol groups
located on the actin microfilaments which are sensitive to
oxidation, leading to cross linking and reduced motility
[18,35], and the cytoskeletal dynamics is regulated by
cytoplasmic calcium.
We have developed protocols to study cytoskeleton asso-
ciated functions in macrophages in vivo and in vitro, such
as phagosome transport, mechanical integrity (viscoelas-
tic properties, stiffness) and phagocytosis, using ferromag-
netic microparticles [36-38]. In in vitro studies the
magnetic microparticles (1.8 µm diameter) are incubated
for 24 hours together with cultivated macrophages, after
which more than 95% are ingested. The particles are then
magnetized and aligned in a short magnetic field pulse,
and can be detected by a magnetic field sensor. Intracellu-
lar phagosome transport causes stochastic disorientations
of the particles, which results in a decay of the remanent
magnetic field of the cell probe (relaxation). In addition
mechanical viscoelastic properties of the cytoskeleton can
be investigated by twisting the micromagnets in a weak
magnetic field. This method is called 'Magnetic Twisting
Cytometry' (MTC) [39,40] and has been used to investi-
gate the role of the different cytoskeletal structures in mac-
rophage function after co-incubation with cytoskeletal
drugs (Cytochalasin D, Nocodazole [37]). Additionally it
has been shown that MTC can monitor cytotoxicity of
GaAs-particles  in vivo in lung macrophages of animals
[41,42] and in vitro caused by ultrafine particles [20].
In this study, we have investigated the role of intracellular
calcium transients produced by environmentally relevant
fine and ultrafine model particles in the induction of
adverse reactions on the cytoskeleton of macrophages,Particle and Fibre Toxicology 2005, 2:7 http://www.particleandfibretoxicology.com/content/2/1/7
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using the MTC technique. Cultivated macrophages from
the cell line J774A.1 were incubated with increasing
amounts of particles. Intracellular phagosome transport
(relaxation), stiffness of the cytoskeleton and cell viability
was recorded. Particles on the basis of carbon black (CB)
having different chemical compositions and impurities,
and a wide range of diameters (12 nm - 1.5 µm) and spe-
cific surface areas (≈ 1 m2/g - 600 m2/g) were tested.
Materials and methods
Target cells
J774A.1 macrophages originate from a BALB/c/NIH
mouse [43] and were obtained from the German Collec-
tion of Animal Cell Cultures (Tumorbank, DKFZ Heidel-
berg, Germany). Cells were grown in RPMI 1640 Medium
(Sigma, Taufkirchen, Germany), supplemented with 5%
fetal calf serum (FCS), 100 U/ml penicillin, 100 µg/ml
streptomycin, 2.5 µg/ml amphotericin and 0.3 g/L-
glutamine in NaHCO3. The cell culture grows with a dou-
bling time of 2 days and was sub-cultured every 4 days. In
cytotoxicity studies cells were incubated with particles and
with Calcium agonists in serum-free medium. In addition
cells were incubated with 5% FCS to test the possible cyto-
toxic effect of lack of serum in the medium.
Magnetic particle binding assay
A number of 0.2 million macrophages were incubated
with 10 µg of 1.8 µm spherical ferromagnetic microparti-
cles in glass vials (12 mm outer diameter) for 24 hours
prior to adding calcium antagonists or ultrafine particles.
This ensured the adherence of the macrophages and more
than 95% phagocytosis of the magnetic beads. Before the
addition of UFP or calcium antagonists, non-adherent
cells and free particles were removed by washing with
medium. Ferromagnetic 1.8 µm magnetite microparticles
(beads) were prepared with narrow size variation (geo-
metric standard deviation < 1.1) and spherical shape [44],
which is important for data analysis using mathematical
models to estimate the viscous and elastic properties of
the cytoskeleton. The particles were not further coated in
order to avoid the activation of specific cell surface recep-
tors. It is reported that the non-specific Scavenger-receptor
mediates phagocytosis of the magnetite particles [45].
Ultrafine test-particles and calcium modulating drugs
Table 1 gives an overview of the test particles used in the
study, together with their physical properties. Because
most urban particles result from combustion processes,
the dominant fraction contains fine and ultrafine carbon-
aceous particles. Ultrafine carbon (EC90) particles were
produced by an electrical spark generator [46] under
standardized conditions with low impurities (for example
transition metals, polycyclic hydrocarbons; about 5%
organic carbon). The mobility diameter in air of these par-
ticles was 90 nm and the high specific surface area of 600
m2/g indicated that aggregates had much smaller subu-
nits. Alternatively, commercially available ultrafine car-
bon particles were used (Printex, P90, Degussa, Frankfurt,
Germany), which have low organic impurities of (≈ 1%),
but some impurities of transition metals (iron etc.). Diesel
particulate matter (Standard Reference Material 1650,
DEP) and urban dust (Standard Reference Material 1649a,
UD) were used to simulate environmental particle expo-
sure [47,48]. The certificate of analysis of UD does not
give an estimation of the specific surface area; therefore a
value from literature was obtained for a comparable
urban dust (PM2.5) probe [49]. The particles were sus-
pended within glass tubes in deionised water by ultrason-
ication and then further diluted in medium without
serum. Microscopic investigation showed that a large frac-
tion of the carbonaceous particles appeared as aggregates
in the cell probes.
Particles were incubated at concentrations of 100 and 320
µg/ml/million cells for 4 h in serum-free medium, or in
combination with calcium antagonists, such as Verapamil
(100 µM, Ca2+ channel blocker), BAPTA-AM (20 µM, Ca2+
chelator), or W-7 (N-(6-aminohexyl)-5-chloro-1-naph-
thalene-sulfonamide hydrochloride, 25 µM, calmodulin
inhibitor). The concentration of the Ca-antagonists was
obtained from previous studies and tested for non-toxic
responses in own preliminary studies. The antioxidant
Table 1: Fine and ultrafine test particles used in the study together with their physical properties, such as count median diameter and 
specific surface area. Elemental carbon particles (EC90) were prepared in own laboratory (GSF-IHB, [46]).
Material type Diameter Specific surface area Source
Printex90 (carbon, P90) 12 nm 300 m2/g Degussa
Elemental carbon (EC90) 90 nm+ 600 m2/g GSF-IHB
Diesel exhaust particles (DEP) 120 nm 108 m2/g NIST*
Urban dust (UD) 1.5 µm ≈ 1 m2/g++ NIST*
+ size of the airborne agglomerates; primary particles are expected to be < 10 nm [46].
* National Institute of Standards and Technology (NIST), Washington, USA [47, 48].
++estimated from other PM2.5 ([49])Particle and Fibre Toxicology 2005, 2:7 http://www.particleandfibretoxicology.com/content/2/1/7
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Nacystelin (NAL, 200 µM) was also included. Nacystelin
(NAL), a thiol antioxidant compound that is a lysinated
derivative of N-acetyl cysteine (NAC), possesses potent
mucolytics capacities and has been shown to inhibit reac-
tive oxygen species effects [50]. It has the advantage of
having a neutral pH compared with NAC, which is acidic,
and thus can be administered to the airways without the
local airway irritation that occurs with NAC. Additionally
the role of serum (FCS, 5%) or bovine serum albumin
(BSA, 1%) in the medium was investigated. In some
experiments long-term incubation (24 hours) was carried
out to compare with previous data.
Cell viability
Cell viability was tested by the propidium iodide (PI)
exclusion test. Necrotic cells allow the penetration of PI
into the cell and the nucleus, where the fluorescent dye
can be visualized. After 10 min PI incubation with adher-
ent cells, the probes were analyzed by fluorescence micro-
scopy, using an inverted microscope (Axiovert 25, Zeiss
GmbH, Jena, Germany) together with a mercury-arc lamp
and a filter system for the detection of propidium iodide
(PI) dye and a digital camera system (CoolSnap-pro,
Mediacybernetics Inc., Silver Spring, MD, USA). Digital
images were recorded and processed using Image Pro soft-
ware package (Mediacybernetics Inc., Silver Spring, MD,
USA). For every probe a transmission image was recorded
as well as a fluorescence image. The transmission image
was used to count the total number of cells in a region of
interest (ROI), defined by a grid overlay and covering
about 80–100% of the image. Each ROI covered at least
100 cells. In the second fluorescence image the number of
PI positive cells was analyzed in the same ROI, allowing
the fraction of dead cells (PI+) to be assessed.
Magnetic twisting cytometry
For in vitro measurement of relaxation and viscoelastic
cell properties a magnetic twisting cytometry device
(MTC) was used [40]. A glass vial (12 mm diameter) con-
taining adherent macrophages with ingested magnetic
particles is positioned in a second gradiometer array of
flux-gate sensors (Förster GmbH, Reutlingen, Germany;
Figure 1). The particles in the cells were aligned parallel to
the direction of the sensors by a 200 mT, 10 µs magnetic
field pulse. The probe was rotated at 6 Hz and the signal
of the fluxgate array was amplified and phase sensitive
detected which significantly reduced system noise and
improved the sensitivity. 10 µg of ferromagnetic particles
induce a remanent magnetic field (RMF) of ≈ 1 nT in the
sensor array. Particle twisting was performed in a mag-
netic twisting field (1 – 2, 5 mT) perpendicular to the
direction of detection (parallel to the axis of rotation).
Stochastic phagosome motion (relaxation)
The motion of vesicles and phagosomes happens contin-
uously within living cells and is part of the intracellular
transport system. Relaxation describes the decay of the
magnetic field after particle alignment in a magnetic pulse
field and originates from the randomization of the mag-
netic particles. We assume that the phagosomes are cou-
pled to the cytoskeletal filaments by motor proteins and
that the hydrolization of ATP provides the energy to move
Magnetic twisting device to measure relaxation and twisting (10 sec) of aligned ferromagnetic microparticles ingested by mac- rophages and detection by an array of magnetic fluxgate sensors (Förster devices, Förster GmbH, Reutlingen, Germany) Figure 1
Magnetic twisting device to measure relaxation and twisting (10 sec) of aligned ferromagnetic microparticles ingested by mac-
rophages and detection by an array of magnetic fluxgate sensors (Förster devices, Förster GmbH, Reutlingen, Germany).Particle and Fibre Toxicology 2005, 2:7 http://www.particleandfibretoxicology.com/content/2/1/7
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the phagosomes and to induce rotational random kicks to
the phagosome [33,39,51,52]. A hydrodynamic relaxa-
tion model was developed under the assumption that the
intracellular randomization energy Er behaves like ther-
mal energy kT, implying a rotational Brownian motion
process together with an exponential decay in a Newto-
nian viscosity. The hydrodynamic relaxation model was
fitted to the experimental data by a non-linear regression
algorithm. Additionally two robust relaxation parameters
were analyzed, being independent of any model (Figure
2A). This is the normalized RMF after 1 minute, b1 = B(1
min)/B0, which characterizes the initial fast phase of
decay, and that after 5 minutes, b5 = B(5 min)/B0, which
is characteristic for the decay in the following slow phase.
Figure 2A illustrates the decay of aligned particles and the
impairment by UFP and by Cytochalasin D, a microfila-
ment disruption agent.
Magnetic phagosome twisting
Application of a weak magnetic field BTW induces twisting
of a magnetic dipole particle and allows investigating
cytoplasmic rheology and mechanical integrity [36,53].
Particles being suspended in a viscosity η  rotate in an
external twisting force according to Newton's law:
where dθ/dt is the shear rate and σ is the applied shear
stress ( , M = remanent magnetization of par-
ticles, κ = rotational shape factor). In case of elasticity the
applied stress is proportional to the elastic deformation
(strain θ) and we get with the elasticity modulus ν Hook's
law:
σ = νθ (2)
Measurement of stochastic intracellular phagosome transport (relaxation, A) and cytoskeletal stiffness (B) by Magnetic Twisting  Cytometry (MTC) Figure 2
Measurement of stochastic intracellular phagosome transport (relaxation, A) and cytoskeletal stiffness (B) by Magnetic Twisting 
Cytometry (MTC). Control and cytochalasin D (CyD) probes do not contain UFP. Other probes show co-incubation with 100 
µg/ml P90 without serum (w/o FCS) and with 100 µM Verapamil or 20 µM BAPTA-AM for 4 hours.
ση
θ
= ()
d
dt
,1
σ
κ
∝
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Strain was estimated from the measurement of the cell
field B(t) according to θ(t) = arccos B(t)/B0. First the parti-
cles were magnetized and aligned parallel to the field sen-
sors (Figure 2B). After 20 sec relaxation the twisting field
was applied for 10 sec duration and viscoelastic recoil was
recorded for another 3 minutes. Viscoelastic recoil does
not force the dipoles back to the undisturbed relaxation
curve, indication of viscous shear, which can reflect a per-
manent deformation (break of filamentous interactions)
of the cytoskeletal structure. Figure 2B shows the change
of particle alignment during magnetic field twisting
together with the elastic recoil in comparison to a relaxa-
tion curve recorded without any external forces to the
magnetic beads. Permanent deformation is characterized
by the difference in complete elastic recoil and undis-
turbed relaxation, as illustrated in Figure 2B. Cell stiffness
was estimated as the ratio between mean stress and strain
after a constant twisting duration of 10 sec. This analysis
of particle twisting does not view specific viscous or elastic
properties. Therefore this parameter provides an integral
description of the cytoskeletal mechanical properties.
Data analysis
The data presented in Figures 3 and 4 under the influence
of particles or drugs are normalized to results of control
probes without particle co-incubation. An inhibited relax-
ation (slower decay, higher b5) results then in a normal-
ized value larger than one. An accelerated relaxation
displays as a normalized value smaller than one. Every set
of UFP/calcium antagonist measurements was performed
on at least 5 separate probes together with a separate set of
control measurements. All parameters estimated under
the set of antagonists were normalized to the set of control
measurements. A significant deviation of the normalized
parameters from unity denotes an influence of the UFP/
antagonist. Using a 2-sided Student's t-Test, deviations
from unity were analyzed for their level of statistical sig-
nificance. An influence by the appropriate antagonist was
accepted when the level of significance was p < 0.05. Pear-
son's correlation analysis was performed using WINSTAT,
Version 2001.1, Fitch Software, Cambridge, USA.
Relaxation of ingested magnetic particles (A, relative decay after 5 min, b5, normalized to control probes without particles) and  mechanical integrity (B, stiffness, mean between low and high stress) of J774A.1 macrophages after 4 h incubation with different  types of 100 µg ultrafine particles/ml/million cells under different incubation conditions, such as without serum (w/o FCS), 100  µM Verapamil, 20 µM BAPTA-AM or 25 µM W-7 (normalized values +/- SD; N = 5; **: p < 0.01, *: p < 0.05) Figure 3
Relaxation of ingested magnetic particles (A, relative decay after 5 min, b5, normalized to control probes without particles) and 
mechanical integrity (B, stiffness, mean between low and high stress) of J774A.1 macrophages after 4 h incubation with different 
types of 100 µg ultrafine particles/ml/million cells under different incubation conditions, such as without serum (w/o FCS), 100 
µM Verapamil, 20 µM BAPTA-AM or 25 µM W-7 (normalized values +/- SD; N = 5; **: p < 0.01, *: p < 0.05).Particle and Fibre Toxicology 2005, 2:7 http://www.particleandfibretoxicology.com/content/2/1/7
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Results
Influence of UFP on phagosome motion and on magnetic 
particle twisting
The results of stochastic intracellular phagosome trans-
port and of cytoskeletal mechanical integrity after 4 hours
of incubation of J774A.1 macrophages with 100 µg/ml
fine or ultrafine particles are shown in Figure 3 (summa-
rized in Table 2 and Table 3). Compared to cells without
particles (control), P90 and EC90 cause a retardation of
relaxation both, for concentrations of 100 µg/ml and of
320 µg/ml (data not shown). This retardation is not seen
for DEP or UD particles. The retardation of relaxation can
be inhibited in part by the co-incubation with Verapamil,
but not with BAPTA-AM. Co-incubation of W-7 with 100
µg/ml P90 in part inhibits the retardation of relaxation,
while it does not with 100 µg/ml EC90 particles. UD sig-
nificantly retarded relaxation only at the high concentra-
tion of 320 µg/ml; the retardation could be inhibited by
the calcium antagonists. The measurements of cytoskele-
tal stiffness (Figure 3B) reflect the same results as were
found on relaxation measurements. P90 and EC90 cause
an increase of cytoskeletal stiffness, when no serum is
present. Verapamil lower the stiffening caused by P90 or
by EC90. W-7 inhibited the stiffening only for P90 co-
incubation, but not with EC90. BAPTA-AM did not influ-
ence the particle induced stiffening for both particle types.
The higher particle concentration of 320 µg UFP/ml
reflects a comparable response. The urban particles (DEP
or UD) do not modulate cytoskeletal stiffness, neither
alone or in combination with calcium antagonists (data
not shown). In summary the data show cytoskeletal dys-
functions caused by P90 and EC90, but not by DEP and
by UD. Cytoskeletal dysfunctions can be inhibited in part
by the Ca2+ channel blocker Verapamil and by the cal-
modulin inhibitor W-7, but not by the Ca2+ chelator
BAPTA-AM.
Influence of serum, BSA and Nacystelin on phagosome 
motion and on magnetic particle twisting
Figure 4 shows the results of serum and of BSA on phago-
some transport and on cytoskeletal stiffness after co-cul-
ture with P90 and EC90 (summary in Table 2 and Table
3). Both, 5% FCS and 1% BSA are able to inhibit the par-
ticle induced retardation of relaxation (Figure 4A) and the
Relaxation of ingested magnetic particles (A, relative decay after 5 min, b5, normalized to control probes w/o particles) and  mechanical integrity (B, stiffness, mean between low and high stress) of J774A.1 macrophages after 4 h incubation with different  types of 100 µg ultrafine particles/ml/million cells under different incubation conditions, such as without (w/o) and with 5%  serum (wFCS), 1% bovine serum albumin (BSA) or 200 µM Nacystelin (NAL); normalized values +/- SD; N = 5; **: p < 0.01, *:  p < 0.05 Figure 4
Relaxation of ingested magnetic particles (A, relative decay after 5 min, b5, normalized to control probes w/o particles) and 
mechanical integrity (B, stiffness, mean between low and high stress) of J774A.1 macrophages after 4 h incubation with different 
types of 100 µg ultrafine particles/ml/million cells under different incubation conditions, such as without (w/o) and with 5% 
serum (wFCS), 1% bovine serum albumin (BSA) or 200 µM Nacystelin (NAL); normalized values +/- SD; N = 5; **: p < 0.01, *: 
p < 0.05.Particle and Fibre Toxicology 2005, 2:7 http://www.particleandfibretoxicology.com/content/2/1/7
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increase in cell stiffness (Figure 4B). The antioxidant
Nacystelin does not inhibit the particle induced
cytoskeletal dysfunctions. Serum, BSA and Nacystelin do
not influence any of the effects of DEP or UD, therefore,
the data are not shown.
Influence on cell viability
After 4 hours incubation time none of the particles or
drugs decreased cell viability to below 90% at a particle
concentration of 100 µg/ml/million cells. Figure 5 shows
the results of the cytotoxicity test (PI exclusion) of the
J774A.1 cells for a particle concentration of 320 µg/ml
and 4 hours incubation time. P90 and EC90 significantly
enhanced the fraction of dead cells in medium w/o serum,
which in part could be suppressed by Verapamil and W-7,
but not by BAPTA-AM. In addition FCS and BSA, but not
NAL reduced the fraction of dead cells after co-culture
with P90 or EC90. Compared to control, there was no sig-
nificant increase in the fraction of dead cells after co-cul-
ture with DEP or DU. An incubation time of 24 hours
further enhanced the cytotoxic effect of the UFP (data not
shown). The viability of the cells under control conditions
(w/o particles) was about 90% with FCS, BSA or NAL and
decreases to about 80% w/o FCS (p < 0.01 compared to 4
hours incubation time). 24 h incubation with the Ca-
modulating drugs showed a reduced viability of 80% for
Verapamil and BAPTA-AM, and 70% for W-7. This reflects
non-physiological conditions of the Ca-modulating
antagonists after long-term exposure. 320 µg/ml P90 and
EC90 raised the fraction of dead cells to up to 80% and
the effect of the Ca-modulating drugs was not uniform.
Long-term co-culture with DEP did not raise the fraction
of dead cells, compared to control incubation conditions.
UD caused a doubling of the fraction of dead cells, which
could be inhibited in part by co-culture with Verapamil,
W-7, and with NAL, but not with BAPTA-AM.
Discussion and conclusion
Necrosis caused by UFP
Figure 5 shows both the cytotoxic potential of the particles
in inducing cell necrosis used in the study, together with
the Ca-modulating antagonists, particularly after 4 hours
incubation time. The ultrafine carbon black particles (P90
and EC90) had the most significant effect on cell viability,
with a doubling of the fraction of dead cells after 4 hours
and a triplication after 24 hours. EC90 particles caused
more dead cells due to the higher specific surface area
compared to P90. FCS and BSA both reduce the cytotoxic
potential of P90 and EC90. In the presence of FCS or BSA,
the particle surface may become coated with proteins,
which may shield reactive sites on the particle surface and
reduced the potential of causative oxidative reactions.
Although serum free medium allows clearer experimental
conditions in case of receptor dependent responses, the
serum co-culture may be closer to physiological condi-
tions in the lung, where surfactant coats and opsonizes
the particles. On the other hand the inhibitory effects of
the Ca-antagonists would not have been seen with the
presence of serum in the medium. Long-term incubation
of J774A.1 macrophages without serum induced a
decrease in cell viability, showing that this by itself is a
non-physiological condition. Interestingly, cell viability
could be enhanced by the presence of serum or BSA in the
medium. But for short time periods (4 hours), the absence
of serum did not injure the cells.
DEP and UD produce less cytotoxicity compared to the
pure carbon black particles, despite other reactive material
may be present, like transition metals, and adsorbed
organic substances. One reason for the lower cytotoxicity
of DEP and UD may be the lower specific surface area. In
a previous study we could show cytoskeletal dysfunctions
caused by DEP and UD after 24 hours incubation time
[20]. In this study different incubation conditions were
Table 2: Summary of effects of 100 µg particles/ml/million cells 
on phagosome transport (relaxation) together with effect of co-
incubation with different Ca-modulating drugs (100 µM 
Verapamil, 20 µM BAPTA-AM or 25 µM W-7) as well as medium 
with serum (wFCS), with bovine serum albumin (BSA), or with 
200 µM Nacystelin (NAL); inhib. – inhibition, n.e. – no effect, 
accel. – acceleration; N = 5; **: p < 0.01, *: p < 0.05.
Drug P90 EC90 DEP UD
w/oFCS inhib.** inhib.** accel.* n.e.
Verap inhib.* n.e. n.e. n.e.
BAPTA inhib.** inhib.** n.e. n.e.
W-7 inhib.** inhib.** n.e. n.e.
wFCS n.e. n.e. n.e. n.e.
BSA n.e. n.e. n.e. n.e.
NAL inhib.** inhib.** n.e. n.e.
Table 3: Summary of effects of 100 µg particles/ml/million cells 
on cytoskeletal stiffness together with effect of co-incubation 
with different Ca-modulating drugs (100 µM Verapamil, 20 µM 
BAPTA-AM or 25 µM W-7) as well as medium with serum 
(wFCS), with bovine serum albumin (BSA), or with 200 µM 
Nacystelin (NAL); stiff. – stiffening, n.e. – no effect; N = 5; **: p < 
0.01, *: p < 0.05.
Drug P90 EC90 DEP UD
w/oFCS stiff.* stiff.** n.e. n.e.
Verap stiff.* n.e. n.e. n.e.
BAPTA stiff.** stiff.** n.e. n.e.
W-7 n.e. stiff.** n.e. n.e.
wFCS n.e. n.e. n.e. n.e.
BSA n.e. n.e. n.e. n.e.
NAL stiff.** stiff.** n.e. n.e.Particle and Fibre Toxicology 2005, 2:7 http://www.particleandfibretoxicology.com/content/2/1/7
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used, where particles were dispersed in medium contain-
ing serum. It was shown that the particles form larger
aggregates without serum proteins in the medium, caus-
ing particle clusters in the µm-size range [54]. Such clus-
ters are subject to different mechanisms of uptake and
processing by the cells (phagocytosis versus endocytosis
for smaller particles), although both are actin based
mechanism. Phagocytosed materials are processed via the
lysosomal digestion route, which is not the case after
endocytosis. In addition the specific surface area is smaller
for aggregated particles. It was also shown that organics
adsorbed to the particle surface can lower the specific sur-
face area, can shield reactive sites; therefore make the par-
ticles less toxic than plain particles [55]. We suggest here
that the organic substances are stable when bound to the
surface, in conjunction with low concentrations in the
medium. The bound organics on the particles may cause
a surface coating, which can shield reactive sites of the car-
bonaceous core.
Influence of UFP on phagosome motion and on magnetic 
particle twisting
MTC studies investigate the transport of micron-sized
phagosomes from two different perspectives. Relaxation
directly monitors the coupling dynamics between phago-
somes and the cytoskeleton [39] while phagosome
twisting examines the mechanical integrity (viscoelastic
properties, stiffness) of the cytoskeletal filaments, which
are linked to the phagosomes [56]. Phagosome transport
requires an intact cytoskeleton, intact phagosomes includ-
ing motor proteins and energy (ATP) [33,57]. Addition-
ally, intracellular calcium plays an important role for
cytoskeletal functions and intracellular signaling in rela-
tion to immunological and non-immunological defense
reactions [58,59]. Cytotoxic reactions can involve the
energy metabolism of the cell, intracellular calcium tran-
sients [13], the dynamics of cytoskeletal filaments and the
transport mechanisms of phagosomes [41,42]. A previous
study has shown that destroying microfilaments by cyto-
chalasin D resulted in a retarded relaxation and an
increased stiffness [37,53]. Colchicine, which disrupts
Cell viability (PI exclusion) of J774A.1 macrophages after 4 hours of incubation without (control) and with 320 µg UFP/ml/mil- lion under different incubation conditions Figure 5
Cell viability (PI exclusion) of J774A.1 macrophages after 4 hours of incubation without (control) and with 320 µg UFP/ml/mil-
lion under different incubation conditions. A): without serum (w/oFCS), 100 µM Verapamil, 20 µM BAPTA-AM and 25 µM W-
7. B): w/oFCS, with 5% serum (wFCS), 1% bovine serum albumin (BSA) or 200 µM Nacystelin (NAL); mean +/- SD, **: p < 
0.01, *: p < 0.05.Particle and Fibre Toxicology 2005, 2:7 http://www.particleandfibretoxicology.com/content/2/1/7
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microtubuli, results in an accelerated relaxation and in a
moderately increased stiffness. Figure 2A illustrates the
retardation of relaxation caused by 100 µg/ml P90, and
the modulation by Verapamil and BAPTA-AM together
with the retardation produced by 4 µM Cytochalasin D. In
comparison to the effects induced by the cytoskeletal
drugs the dysfunctions produced by the carbonaceous
UFP suggests destructions of microfilamentous structures
and hence dysfunctions of the cytoskeleton. This is also in
agreement with other studies which showed impairment
of the phagocytic capacity (an actin based mechanism)
after incubation with different types of UFP [19,20].
Intracellular calcium plays a central role in the modula-
tion of the defense mechanisms causing inflammation.
Further studies have shown that ufCB causes a transient
increase of intracellular calcium, which can be inhibited
by the calcium channel blocker Verapamil [13,60]. This
was reflected in this study by the inhibition of ufCB
induced cytoskeletal dysfunctions in the presence of Vera-
pamil. Interestingly, the intracellular calcium chelator
BAPTA-AM did not induce the expected suppression of
cytoskeletal dysfunction. The reason for this lack of effect
is not clear but suggests that not only the level of intracel-
lular calcium is responsible for the ufCB induced
dysfunctions.
Calmodulin (CaM) is a ubiquitous calcium binding pro-
tein that can bind to and regulate a multitude of different
protein targets by affecting many different cellular func-
tions. CaM mediates processes such as inflammation,
metabolism, apoptosis muscle contraction and cellular
movement. It has been shown that calmodulin has a
direct impact on actin polymerization [61-63], acto-
myosin binding and cross linking [64,65]. CaM is thought
to activate the myosin light chain kinase (MLCK) and
CaM kinase II by displacement of their auto inhibitory
domains. Many of the proteins that bind CaM are unable
to bind calcium themselves and as such use CaM as a cal-
cium sensor and signal transducer. The fact that the CaM-
inhibitor W-7 can suppress most of the cytotoxic reactions
caused by ufCB co-culture shows that the calcium depend-
ent signaling pathway is crucial for the cytotoxic effect and
cytoskeletal dysfunctions. The lack of suppression after
co-culture with EC90 particles may reflect their higher
specific surface area.
The antioxidant Nacystelin did not inhibit the UFP
induced dysfunctions of the cytoskeleton. Oxygen radicals
cause an oxidation and depletion of cytoskeletal proteins
(thiols), disruption of actin filaments and the inhibition
of F-actin formation, and an actin cross linking [18]. The
actin system is the most sensitive constituent of the
cytoskeleton to the oxidant attack. Nacystelin can inhibit
the thiol oxidation [66], but did not result in a suppres-
sion of UFP induced cytoskeletal dysfunctions. This shows
that the thiol oxidation may not be the only response to
UFP exposure (besides the modulation of the calcium
metabolism), but the cross linking of actin filaments pri-
marily may describe the retarded relaxation and the
increased stiffness of the cytoskeleton.
The specific surface area of the particles is discussed to be
a significant parameter relating to cytotoxic responses of
ultrafine particles [16,67]. Our studies in part support this
hypothesis. Cell viability seems to correlate with the spe-
cific surface area of the particles, where EC90 induces
more dead cells compared to P90 or to UD and DEP.
Impairment of relaxation and stiffening of the cytoskele-
ton seem not to depend on the specific surface area, but
W-7 could inhibit the particle induced impairments in
P90, but not in EC90, which has the higher specific sur-
face area. Besides the different surface characteristics of
DEP and UD compared to EC90 and P90, the lack of
cytoskeletal dysfunctions of these materials seems to be in
part induced by the smaller specific surface area.
List of abbreviations
UFP ultrafine particles
ufCB ultrafine carbon black
PM2.5 particle mass with aerodynamic diameter <= 2.5
µm
EC90 elemental carbon particles, 90 nm mobility
diameter
P90 commercial carbon particles, Printex 90 (Degussa)
DEP diesel exhaust particles
UD urban dust
W-7 (N-(6-aminohexyl)-5-chloro-1-naphthalene-sulfon-
amide hydrochloride, 25 µM, calmodulin inhibitor
CaM calmodulin
BAPTA-AM Ca2+ chelator
Verap Verapamil
BSA bovine serum albumin
FCS fetal calf serum
ATP adenosine triphosphate
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ROI region of interest
MTC magnetic twisting cytometry
RMF remanent magnetic field of cell/magnetic particle
probe
b1 = B(1 min)B0 RMF after 1 min relaxation
b5 = B(5 min)B0 RMF after 1 min relaxation
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